P. de la Cueva Dobao-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)

    Dermatology and Therapy, Vol. 13, Núm. 1, pp. 329-345

2013

  1. Expert Report on Psoriasis: Spanish Dermatologists' Opinions on the Use of Biologic Agents to Manage Moderate to Severe Psoriasis in Adults

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 5, pp. 400-408